Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Fluorogen/soluble FAP binding competition assay
Assay data:2 Active, 2 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by DepositorRelated BioAssays by Same ProjectRelated BioAssays by Target
Evaluation of reversibility of compound binding to AM2.2-beta2AR cells with Powder Set 3and4
Assay data:12 Active, 12 Tested
Counter screen for HTS for Beta-2AR agonists with FAP-tagged GPR32 with Powderset5
Assay data:3 Active, 2 Activity ≤ 1 µM, 13 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Same ProjectRelated BioAssays by Target
Counter screen for HTS for Beta-2AR agonists with FAP-tagged human CCR5 with Powderset5
Assay data:5 Active, 4 Activity ≤ 1 µM, 13 Tested
Dose response for HTS for Beta-2AR agonists via FAP method from Powderset5
Assay data:7 Active, 6 Activity ≤ 1 µM, 13 Tested
Counter screen for HTS for Beta-2AR agonists with FAP-tagged GPR32 with Powderset4
Assay data:5 Active, 5 Activity ≤ 1 µM, 29 Tested
Counter screen for HTS for Beta-2AR agonists with FAP-tagged human CCR5 with Powderset4
Assay data:6 Tested
SummaryPubMed CitationRelated BioAssays by DepositorRelated BioAssays by Same ProjectRelated BioAssays by Target
Dose response for HTS for Beta-2AR agonists via FAP method from Powderset4
Assay data:6 Active, 5 Activity ≤ 1 µM, 29 Tested
Cytotoxicity Dose Response with AM2.2-beta2AR cells for PowderSet4
Assay data:3 Active, 7 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by DepositorRelated BioAssays by Same Project
Counter screen for HTS for Beta-2AR agonists with FAP-tagged human CCR5 with Powderset3
Assay data:19 Active, 14 Activity ≤ 1 µM, 32 Tested
Counter screen for HTS for Beta-2AR agonists with FAP-tagged human GPR32 with Powderset3
Assay data:20 Active, 15 Activity ≤ 1 µM, 32 Tested
Counter screen for HTS for Beta-2AR agonists with FAP-tagged GPR32 with Powderset2
Assay data:4 Active, 4 Activity ≤ 1 µM, 8 Tested
Counter screen for HTS for Beta-2AR agonists with FAP-tagged human CCR5 with Powderset2
Summary of HTS Screening Project for Inhibitors of fluorogen-FAP tag interactions
Counter screen for HTS for Beta-2AR agonists with FAP-tagged mouse CCR5 with Powderset1
Assay data:20 Tested
Cytotoxicity Dose Response with AM2.2-beta2AR cells for PowderSet01
Assay data:2 Active, 8 Tested
Dose response for HTS for Beta-2AR agonists via FAP method from Powderset3
Assay data:21 Active, 15 Activity ≤ 1 µM, 32 Tested
Dose response for HTS for Beta-2AR agonists via FAP method from Powderset2
Assay data:3 Active, 1 Activity ≤ 1 µM, 8 Tested
Dose response for HTS for Beta-2AR agonists via FAP method from Powderset1
Assay data:20 Active, 17 Activity ≤ 1 µM, 20 Tested
Summary of HTS for Non-Canonical Ligands for Beta 2 Adrenergic Receptor Internalization
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on